about
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysisTerms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) groupUterine perfusion and hormonal pattern in patients with polycystic ovary syndromeStrategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupEvidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome.Clinical applications of colour Doppler energy imaging in the female reproductive tract and pregnancy.Contribution of power Doppler blood flow mapping to gray-scale ultrasound for predicting malignancy of adnexal masses in symptomatic and asymptomatic women.External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.Imaging in gynaecology: How good are we in identifying endometriomas?Ovarian tumor characterization and classification using ultrasound-a new online paradigm.Mature and immature ovarian teratomas: CT, US and MR imaging characteristics.Learning curve in the detection of ovarian and deep endometriosis by using Magnetic Resonance: comparison with surgical results.MRI and "tenderness guided" transvaginal ultrasonography in the diagnosis of recto-sigmoid endometriosis.Extragenital endometrial stromal sarcoma arising in endometriosis.Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.Three-dimensional sonography for diagnosis of rectovaginal septum endometriosis: interobserver agreement.Three-dimensional ultrasonography in the diagnosis of deep endometriosis.Endometriosis: the role of magnetic resonance imaging.Ovarian tissue characterization in ultrasound: a review.Past, present and future ultrasonographic techniques for analyzing ovarian masses.Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis.Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis.Overview of elagolix for the treatment of endometriosis.Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group.Malignancy risk of sonographically benign appearing purely solid adnexal masses in asymptomatic postmenopausal women.Tissue characterization using mean gray value analysis in deep infiltrating endometriosis.Age-related differences in the sonographic characteristics of endometriomas.Reproducibility of two different methods for performing mean gray value evaluation of cyst content in endometriomas using VOCAL.Three-dimensional sonographic characteristics of deep endometriosis.Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer.The screening of tubal abnormalities in the infertile couple.Color Doppler energy imaging in the diagnosis of fetal intracranial hemorrhage in the second trimester.Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis.Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment.Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
P50
Q26801372-DA4CA5C0-B016-4F16-9AE4-137E3415A19FQ27023285-103914ED-B235-4140-AD39-BB3DBE8B66BAQ28361496-C488F8F9-8D19-4766-A58B-BC571B3AC289Q30404969-8DC0B12F-E6BA-42D0-949A-D1403C277324Q30428244-ECE60711-5C2B-4681-9AA0-2858832B704DQ30478027-92EFB94A-923A-4394-86BE-3C2384E5018BQ31408801-1FB2DC4A-8A70-41D8-8FA0-E747771987DBQ33740749-EF61B0B5-17BB-4206-9405-85C54177A4CDQ33785464-AC947B98-87B2-4D83-90A9-0BBEFBF8926AQ33787752-2DA78D37-4119-4952-8198-45BE045C562AQ34235622-039BFD98-F1F8-4185-B721-2701F166D84FQ34608220-B3FA0B64-D58D-4498-A976-2060F84DE14FQ36829570-7C04E215-FF61-4FA2-A230-2F0938DCD6AAQ37274550-533E65B2-656D-47EB-ADD1-1A86BCDE1B9CQ37695661-96723D12-834D-4528-8C7B-31C92C6868A2Q37950315-FCF3DA81-8851-47D0-BEA7-2B800086C499Q38005881-0AACB0AC-A458-4CCD-A157-6CF79C827CFFQ38045841-F812B41D-88AC-4132-8151-912E1C86F64AQ38110259-BBD4FD5F-3A69-4A0F-814C-7157C69F787AQ38198969-490810B9-1E6F-40CE-B687-CAA2923188B4Q38199957-033F501F-B0A7-4064-8527-4C323041FB0DQ38250447-E4688D7E-6844-43B8-80E8-E4B3EB3DDA5BQ38535377-F864A45B-EB4E-48DF-B262-F19ED913279DQ38554989-BE3DF57A-28AF-4061-BB3C-37DBADE67587Q38781907-FA1D3156-62C8-45E5-8026-C54E8BF18988Q38791644-F19018CB-5453-444B-978C-767CB053F634Q38847910-B4544EDD-D7B8-449E-9C88-6603AB1A153EQ39001765-B57957E8-951A-4A6B-A54B-BC77AA991ECFQ39564860-2D2F6C12-AAB3-40EC-955C-03574884B805Q39695513-D161D0BE-D930-4E9B-BBDC-03B790653B6DQ39699087-F8B45960-1AC9-4E09-AE87-FBB19AACF4AEQ39958972-977D7E89-6F6B-46AB-A946-DF94D27CD696Q40072293-A2F29195-3CBE-434D-9E00-F779483DD2E9Q40127403-BD43777D-DB3E-4E11-9DE4-2947CC00154EQ40940719-105C8A66-5964-4261-9316-96A9FD15F5B5Q41618499-99EA2570-3DC8-464D-9E25-8982741C9DBBQ41671103-72F3C44C-B999-4813-8DDA-E3DAA92948D5Q42700296-C60923F7-2C5F-4E8C-98CF-ED37081EB076Q42717625-CB3DA1ED-712B-4AB4-BAEA-96B9BF7ADD72Q42960292-06C49EF3-2ECB-4C19-B10B-B7E253E754DF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Stefano Guerriero
@ast
Stefano Guerriero
@en
Stefano Guerriero
@es
Stefano Guerriero
@sl
type
label
Stefano Guerriero
@ast
Stefano Guerriero
@en
Stefano Guerriero
@es
Stefano Guerriero
@sl
prefLabel
Stefano Guerriero
@ast
Stefano Guerriero
@en
Stefano Guerriero
@es
Stefano Guerriero
@sl
P214
P244
P106
P1153
26037903000
P21
P213
0000 0004 2939 6600
P214
P244
n2014185574
P31
P396
IT\ICCU\CFIV\254592
P496
0000-0002-1359-7155
P569
1961-01-01T00:00:00Z
P734
P735
P7859
lccn-n2014185574